Not applicableActive Not RecruitingNCT05049798
What this trial is testing
Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice
Who this might be right for
Arthritis, Psoriatic
Janssen Pharmaceutica N.V., Belgium 1,314